You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021272012
Dec 20215607
Jan 20225708
Feb 202282020
Mar 2022150024
Apr 202276025
May 2022102030
Jun 202232012
Jul 20227608
Aug 2022166031
Sep 202286014
Oct 202260010
Nov 202276010
Dec 20224406
Jan 20235009
Feb 20234404
Mar 202364016
Apr 202366013
May 20237007
Jun 202340011
Jul 202348015
Aug 20235206
Sep 20236209
Oct 202390010
Nov 2023178018
Dec 202376010
Jan 20243603
Feb 20245007
Mar 20248806
Apr 20248004
May 202484012
Jun 2024130010
Jul 202414408
Aug 202492014
Sep 202498013
Oct 2024192022
Nov 20247606
Total32450450